In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by the ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...

IT’S become one of the most popular ways in the showbiz world to stay slim. But Katherine Ryan has hit back at claims she’s ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

As the drugs have gained name recognition among adults, they’ve also become increasingly popular with children and adolescents. But are the safe?

Alabama now provides partial GLP-1 coverage for obesity: Among the obesity-indicated GLP-1s, Medicaid in Alabama covers just ...

The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...

Because androgens (hormones that women with PCOS have more of) are linked to insulin resistance, they can cause you to store ...

Some of the reality star's fans may be surprised to learn that she didn't set out to lose weight when she first started working out at a gym. "My weight loss journey started because I was getting ...

Every January, millions of people start the new year vowing to lose weight. But in 2025, many of those hoping to shed the ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.